BRG Borregaard

Borregaard ASA: Repurchase of own shares

Borregaard ASA: Repurchase of own shares

28.11.2023: Borregaard ASA (”Borregaard”, OSE ticker: BRG)

Reference is made to the stock exchange notice of 17 November 2023 where Borregaard announced the intent to repurchase up to 200,000 of its outstanding common stock. The repurchase of shares will be conducted in a period from 20th November up to and including 20th December 2023 at the latest.

Borregaard has in the period from 20 November up to and including 28 November 2023 in total purchased 139,796 own shares through broker at an average price of NOK 169.45 per share.

Aggregated overview of transactions per day:

DateAggregated daily volume (number of shares)Weighted average share price per day (NOK)Total daily transaction value (NOK)
20.11.202323,843169.74824,047,306.33
21.11.202323,843169.79954,048,529.48
22.11.202323,843167.42163,991,833.21
23.11.202312,739169.33152,157,113.98
24.11.202317,905169.73943,039,183.96
27.11.202318,675170.61563,186,246.33
28.11.202318,948169.80753,217,512.51
    
    
Previously disclosed buys under the programme (accumulated)n.a.n.a.n.a.
Accumulated under the buy-back programme139,796169.4523,687,725.80

The issuer’s holding of own shares:

Following the completion of the above transactions, Borregaard owns a total of 383,400 of own shares, corresponding to 0.38% of Borregaard’s share capital.

Appendix:

A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report and available at

Contact:

Lotte Kvinlaug, Investor Relations Officer,  909

This information is subject to the disclosure requirements pursuant to Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 Article 2 section 3 and Section 5-12 of the Norwegian Securities Trading Act.

 

Attachment



EN
28/11/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Borregaard

 PRESS RELEASE

Borregaard ASA: Reporting of transactions in Borregaard ASA's shares m...

Borregaard ASA: Reporting of transactions in Borregaard ASA's shares made by person discharging managerial responsibilities Borregaard's Board of Directors has issued 30,000 share options in relation to the CEO appointment. Reference is made to stock exchange release on 23 May 2025. The options will expire after five years (1 August 2030) and may be exercised in the last two years. The strike price of the options is NOK 219.31, based on the volume-weighted average share price (VWAP) over the last three trading days in July 2025 (29, 30 and 31 July), plus a 10% premium. The strike price wil...

 PRESS RELEASE

Borregaard ASA: New CEO reinforces Borregaard’s commitment to speciali...

Borregaard ASA: New CEO reinforces Borregaard’s commitment to specialisation and value growth Tom Erik Foss-Jacobsen assumed his position as Borregaard’s new CEO on 1 August (see notice to Oslo Stock Exchange 23 May 2025). “Borregaard is well positioned with six production units, three R&D centres, and thirteen sales offices in key markets across Europe, the Americas, and Asia. We will continue to build on this solid foundation and our highly skilled organisation to advance our strategy of specialisation and value growth. Borregaard will continue to build on a strong legacy of specialisati...

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
 PRESS RELEASE

Borregaard ASA: EBITDA1 of NOK 522 million in the 2nd quarter

Borregaard ASA: EBITDA1 of NOK 522 million in the 2nd quarter Borregaard’s operating revenues increased to NOK 2,045 million (NOK 1,949 million)2 in the 2nd quarter of 2025. EBITDA1 reached NOK 522 million (NOK 510 million). The result in BioSolutions and BioMaterials increased while Fine Chemicals had a lower result. Continued growth in sales to agriculture was the main reason for the improved result in BioSolutions. In BioMaterials, the result increased due to higher sales prices, improved product mix and increased sales volume, partly offset by higher wood costs. Lower sales prices for b...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch